Are you looking to implement AI in your vaccine development process?

Meet reverse vaccinology: An AI-driven procedure that allows vaccinologists to determine potential vaccine targets in a faster, cheaper, and more sustainable fashion.

This computational approach starts from a pathogen’s genome and then identifies and prioritises the most promising proteins or peptides that can be used for a novel vaccine. The prioritisation of these targets reduces the number of targets that need to be tested, thereby reducing preclinical development time and cost.

Want to know more? We have just released a white paper on the subject.